<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0227413.ref030">
 <label>30</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pebody</surname>
   <given-names>RG</given-names>
  </name>, 
  <name>
   <surname>Gay</surname>
   <given-names>NJ</given-names>
  </name>, 
  <name>
   <surname>Hesketh</surname>
   <given-names>LM</given-names>
  </name>, 
  <name>
   <surname>Vyse</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Morgan-Capner</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Brown</surname>
   <given-names>DW</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance</article-title>. 
  <source>Vaccine</source>. 
  <year>2002</year>;
  <volume>20</volume>(
  <issue>7–8</issue>):
  <fpage>1134</fpage>–
  <lpage>40</lpage>. 
  <pub-id pub-id-type="doi">10.1016/s0264-410x(01)00435-2</pub-id>
  <?supplied-pmid 11803074?>
  <pub-id pub-id-type="pmid">11803074</pub-id>
 </mixed-citation>
</ref>
